Biography and Research Information
OverviewAI-generated summary
Christopher Parrill's research focuses on understanding the neurological and psychological effects of medications. His recent publication in 2025, "Schizophrenia or Side Effect? Differentiating First-Episode Psychosis From Neuropsychiatric Side Effects of Tacrolimus," investigates the challenges in distinguishing between the symptoms of schizophrenia and the potential neuropsychiatric side effects of the immunosuppressant drug tacrolimus in patients experiencing their first episode of psychosis. Parrill collaborates with Payton Lea at the University of Arkansas for Medical Sciences, with whom he has co-authored one publication. His work contributes to the fields of neuroscience and pharmacology by examining drug-induced neurological changes.
Metrics
- Publications: 1
Selected Publications
-
238. Schizophrenia or Side Effect? Differentiating First-Episode Psychosis From Neuropsychiatric Side Effects of Tacrolimus (2025)
Collaboration Network
Top Collaborators
- 238. Schizophrenia or Side Effect? Differentiating First-Episode Psychosis From Neuropsychiatric Side Effects of Tacrolimus
Similar Researchers
Based on overlapping research topics